Thus, the data suggested that up-regulated miR-34a-3p attenuated pulmonary arterial proliferation in APE rats, with manifestations of increased pulmonary arterial walls thickening as well as NOR-1 and PCNA levels. Here, NR4A3 is linked to apparent mineralocorticoid excess.